{"gene":"VPS39","run_date":"2026-04-28T23:00:23","timeline":{"discoveries":[{"year":1997,"finding":"Vam6/Vps39 (123 kDa) and Vam2/Vps41 physically interact and co-exist as components of a large protein complex on vacuolar membranes in S. cerevisiae. Loss of either protein causes accumulation of small vacuole-related structures (~200–400 nm), inefficient processing of vacuolar proteases (proteinase A, B, carboxypeptidase Y, alkaline phosphatase), and missortng of CPY to the cell surface, establishing their role in vacuolar assembly.","method":"Chemical cross-linking, co-fractionation, GFP-tagging with live imaging, density gradient fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-fractionation, cross-linking, GFP localization with defined loss-of-function phenotypes; foundational paper replicated widely","pmids":["9111041"],"is_preprint":false},{"year":2009,"finding":"Yeast Vam6/Vps39 functions as a guanine nucleotide exchange factor (GEF) for the Rag GTPase homolog Gtr1, loading it with GTP to activate TORC1 in response to amino acids. GTP-bound Gtr1 interacts strongly with TORC1, and Vam6 thereby connects its established role in vacuolar fusion (HOPS complex) to nutrient-sensitive TORC1 regulation via the EGO complex.","method":"GTP-binding assays, constitutively active/dominant-negative Gtr1 mutant expression, TORC1 activity assays, co-immunoprecipitation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — GEF activity demonstrated with nucleotide-binding mutants and TORC1 activity readouts; replicated across two labs in same issue","pmids":["19748353","19748348"],"is_preprint":false},{"year":2007,"finding":"Loss of zebrafish vam6/vps39 (lbk mutant) causes hypopigmentation of melanocytes and RPE, absence of iridophore reflections, defects in liver, intestine, vision, and macrophage function, with accumulation of enlarged intracellular vesicles in affected cells. Positional cloning, allele screening, rescue experiments, and morpholino knockdown confirm vam6/vps39 as causative, establishing its essential role in HOPS-mediated vesicle tethering and fusion in a multicellular organism.","method":"Positional cloning, rescue experiments, morpholino knockdown, electron microscopy, behavioral/physiological assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vivo methods (cloning, rescue, morpholino) with defined cellular phenotypes","pmids":["18077594"],"is_preprint":false},{"year":2010,"finding":"Mammalian Vps39 (mVps39) induces lysosomal clustering when overexpressed, but contrary to expectation for a Rab7 GEF, does not increase Rab7-GTP levels as measured by RILP effector pulldown. A dominant-negative mVps39 mutant fragments lysosomes and promotes growth factor independence without reducing Rab7-GTP, indicating that mVps39 regulates lysosomal morphology and cell survival via a Rab7-GTP-independent mechanism and is not the bona fide Rab7 GEF.","method":"Effector pulldown assay (RILP-based Rab7 activation), dominant-negative mutant expression, lysosome morphology imaging, cell death assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct GTPase activity measurement with effector pulldown plus dominant-negative genetics; multiple orthogonal readouts","pmids":["20363736"],"is_preprint":false},{"year":2010,"finding":"VPS39 (also known as TLP/TRAP1-Like-Protein) is essential for early mouse embryonic development; homozygous VPS39-knockout mice die before E6.5, demonstrating a non-redundant in vivo requirement distinct from the paralog TRAP1.","method":"Knockout mouse generation, embryonic lethal phenotype analysis","journal":"Immunobiology","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined developmental phenotype; single study","pmids":["20961651"],"is_preprint":false},{"year":2012,"finding":"In fission yeast (S. pombe), Vam6 functions upstream of Gtr1/Gtr2 (Rag GTPase homologs) and upstream of TORC1 in an amino-acid-sensing pathway. Epistasis analysis places Vam6 as the upstream activator in the Vam6–Gtr1/Gtr2–TORC1 axis that promotes cell growth and inhibits sexual differentiation, confirming evolutionary conservation of this signaling pathway.","method":"Genetic epistasis analysis, deletion mutants, colocalization imaging, mating/sporulation phenotype assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in an orthologous organism with multiple phenotypic readouts; single lab","pmids":["22344254"],"is_preprint":false},{"year":2014,"finding":"Human CORVET lacks a defined Vps3 subunit; hVps39-2/TRAP1 (a VPS39 isoform) co-localizes with Rab5-positive endosomes and directly binds Rab5-GTP in vitro, identifying it as an effector of Rab5 and the likely Vps3 subunit of the human CORVET complex.","method":"In vitro Rab5-GTP binding assay, co-localization imaging in HEK293 cells and yeast, yeast complementation","journal":"Cellular logistics","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct in vitro binding plus cellular co-localization; single lab","pmids":["25750764"],"is_preprint":false},{"year":2014,"finding":"VPS39 (as a component of the HOPS complex) is required for autophagosome-lysosome fusion in mammalian cells. VPS39 knockdown blocks autophagic flux and causes accumulation of STX17/LC3-positive autophagosomes. HOPS interacts with the autophagosomal SNARE STX17 (co-precipitated via VPS33A/VPS16/VPS39), linking VPS39 to the STX17–SNAP29–VAMP8 SNARE assembly needed for fusion.","method":"siRNA knockdown, immunoprecipitation/mass spectrometry, autophagic flux assays, fluorescence microscopy","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, knockdown with defined autophagic flux phenotype; replicated in multiple subsequent studies","pmids":["24554770"],"is_preprint":false},{"year":2020,"finding":"SARS-CoV-2 ORF3a directly interacts with VPS39, sequestering it in late endosomes, which prevents the HOPS complex from interacting with the autophagosomal SNARE protein STX17, thus blocking assembly of the STX17–SNAP29–VAMP8 SNARE complex required for autophagosome/lysosome fusion and leading to accumulation of unfused autophagosomes. SARS-CoV ORF3a does not interact with HOPS/VPS39.","method":"Co-immunoprecipitation, autophagosome-lysosome fusion assays, fluorescence co-localization, siRNA knockdown, SARS-CoV-2 infection","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — direct binding, SNARE complex assembly assays, knockdown epistasis, infection context; multiple orthogonal approaches","pmids":["33422265"],"is_preprint":false},{"year":2021,"finding":"VPS39 is downregulated in myoblasts and myotubes from individuals with type 2 diabetes. VPS39 knockdown in human myoblasts impairs autophagic flux, dysregulates insulin signaling, alters epigenetic enzyme expression and DNA methylation at myogenic regulator loci, and perturbs differentiation. Vps39+/− mice display reduced muscle glucose uptake and altered expression of genes involved in autophagy, epigenetic programming, and myogenesis.","method":"siRNA knockdown in human myoblasts, RRBS DNA methylation, RNA-seq, autophagic flux assays, heterozygous mouse model with glucose uptake measurement","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function in human primary cells and mouse model with multiple orthogonal molecular and metabolic readouts","pmids":["33893273"],"is_preprint":false},{"year":2021,"finding":"SARS-CoV-2 ORF3a interacts with VPS39 and prevents binding of HOPS to RAB7, blocking the assembly of fusion machinery and causing accumulation of unfused autophagosomes, consistent with VPS39 being the critical HOPS subunit bridging RAB7 interaction for autophagosome–lysosome fusion.","method":"Co-immunoprecipitation, autophagosome-lysosome fusion assays, RAB7-HOPS interaction assays, fluorescence microscopy","journal":"Cell discovery","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and epistasis; largely corroborates Miao et al. 2020 findings","pmids":["33947832"],"is_preprint":false},{"year":2020,"finding":"Yeast Vps39 has a specific role in phosphatidylethanolamine (PE) transport to the mitochondria. Deletion of VPS39 prevents ethanolamine-stimulated elevation of mitochondrial PE without affecting PE biosynthesis in the ER or PE transport to other organelles. Vps39 abundance and its recruitment to mitochondria and ER is regulated by local PE levels, and this function is independent of the intact HOPS or vCLAMP complexes.","method":"Lipid extraction and quantification (TLC, mass spectrometry), subcellular fractionation, genetic deletion of complex subunits, ethanolamine-labeling experiments","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"Medium","confidence_rationale":"Tier 2 — lipid quantification with genetic dissection of complex independence; single lab","pmids":["32058032"],"is_preprint":false},{"year":2020,"finding":"VPS39 controls ciliogenesis in human renal cells by regulating the localization of IFT20 (intraflagellar transport 20) at the base of cilia through autophagy. VPS39 acts as a negative regulator of ciliogenesis, and this function is conserved in vivo in medaka fish renal tubules.","method":"siRNA knockdown in human renal cells, morpholino knockdown in medaka, autophagy modulation, immunofluorescence of IFT20 localization, cilia length/number quantification","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function in cells and in vivo model with defined localization phenotype and pathway (autophagy) link; single lab","pmids":["32077937"],"is_preprint":false},{"year":2022,"finding":"SGPL1 (sphingosine-1-phosphate lyase) upregulation stimulates VPS39 recruitment to the mitochondria, enhancing mitochondria-lysosome membrane contact sites (MCS). VPS39 downregulation compromises mitochondrial network maintenance and basal autophagic flux in MICU1-deficient cells, placing VPS39 as a key effector in SGPL1-mediated organelle interaction and autophagy sustenance.","method":"Quantitative proteomics, transcriptomics, biochemical fractionation, imaging of MCS, VPS39 knockdown, MICU1-deficient C. elegans and mammalian cell models","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — multi-omics plus functional validation across species; single lab","pmids":["35452878"],"is_preprint":false},{"year":2023,"finding":"ASFV protein CP204L binds VPS39 and blocks its association with the lysosomal HOPS complex, redirecting CP204L-VPS39 complexes to virus factories. Loss of VPS39 reduces early viral protein synthesis and delays ASFV replication, demonstrating that VPS39 is exploited by ASFV for early replication steps and is involved in endolysosomal trafficking during infection.","method":"Co-immunoprecipitation, proximity ligation, fluorescence colocalization, VPS39 knockout/knockdown, viral replication assays","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding, knockout phenotype in viral context; single lab","pmids":["36722971"],"is_preprint":false},{"year":2025,"finding":"SARS-CoV-2 ORF3a binds VPS39 and through this interaction: (1) traps the CI-MPR sorting receptor and retromer complex in endosomes/lysosomes, impairing NPC2 cholesterol transporter trafficking; and (2) reduces bis(monoacylglycerol)phosphate (BMP) lipids required for cholesterol export by decreasing lysosome-mitochondrion membrane contact sites (MCS). VPS39 deletion alone decreases MCS and BMPs, identifying VPS39 as a regulator of NPC2 trafficking and BMP biosynthesis.","method":"Lipidomics, proteomics, retromer deletion epistasis, MCS quantification, NPC2 trafficking assays, cholesterol efflux assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal approaches (lipidomics, proteomics, epistasis, MCS imaging); preprint, not yet peer-reviewed","pmids":["39605369"],"is_preprint":true},{"year":2020,"finding":"Crystal structure of the C-terminal putative zinc finger domain of VPS39 was solved, revealing it adopts a non-native anti-parallel β-hairpin fold incorporated into a homotetrameric eight-stranded β-barrel under the recombinant conditions used, stabilized by tag-mediated zinc coordination and an intramolecular disulfide bond rather than the expected zinc finger fold.","method":"Recombinant protein expression, X-ray crystallography","journal":"Wellcome open research","confidence":"Low","confidence_rationale":"Tier 1 method but result is explicitly non-native fold; finding is a cautionary structural observation rather than functional mechanistic insight","pmids":["32724865"],"is_preprint":false}],"current_model":"VPS39 is a core subunit of the HOPS tethering complex that resides on vacuolar/lysosomal membranes, where it promotes late endosome–lysosome and autophagosome–lysosome fusion (via interaction with STX17-containing SNARE complexes and RAB7), and in yeast additionally functions as a GEF for the Rag GTPase Gtr1 to activate TORC1 in response to amino acids; beyond its canonical HOPS role, VPS39 independently participates in mitochondria–lysosome membrane contact sites to regulate phosphatidylethanolamine transport and BMP biosynthesis, is required for muscle stem cell differentiation and glucose uptake through autophagy-epigenetic coupling, and is exploited by viral proteins (SARS-CoV-2 ORF3a, ASFV CP204L) that sequester VPS39 to block autophagic flux or redirect endolysosomal trafficking."},"narrative":{"teleology":[{"year":1997,"claim":"Identification of Vam6/Vps39 as a vacuolar membrane protein that physically associates with Vam2/Vps41 in a large complex essential for vacuolar assembly established VPS39 as a tethering/fusion factor rather than a sorting receptor or protease.","evidence":"Chemical cross-linking, co-fractionation, GFP imaging, and vacuolar protease processing assays in S. cerevisiae","pmids":["9111041"],"confidence":"High","gaps":["Complete subunit composition of the complex not yet defined","Mechanism of membrane tethering unknown","No metazoan homolog characterized"]},{"year":2007,"claim":"Positional cloning of the zebrafish leberknödel mutant demonstrated that VPS39 is essential for HOPS-dependent vesicle fusion in a multicellular organism, extending its role beyond yeast vacuolar biogenesis to pigmentation, liver, intestine, and immune cell function.","evidence":"Positional cloning, rescue, morpholino knockdown, electron microscopy in zebrafish","pmids":["18077594"],"confidence":"High","gaps":["Mammalian in vivo requirement not yet established","Which HOPS subunit interactions are conserved in vertebrates remains undefined"]},{"year":2009,"claim":"Discovery that yeast Vam6/Vps39 acts as a GEF for the Rag GTPase Gtr1 to activate TORC1 revealed that VPS39 links vacuolar fusion to nutrient signaling, answering how amino acid availability is communicated to the growth-control machinery at the vacuolar surface.","evidence":"GTP-binding assays, constitutively active/dominant-negative Gtr1 mutants, TORC1 activity readouts, co-immunoprecipitation in S. cerevisiae","pmids":["19748353","19748348"],"confidence":"High","gaps":["Whether the GEF activity is conserved in mammalian VPS39 was untested","Structural basis of the GEF mechanism unknown"]},{"year":2010,"claim":"Three findings collectively refined VPS39 biology in mammals: mammalian VPS39 does not function as a Rab7 GEF yet regulates lysosomal morphology and cell survival through a GTP-independent mechanism; homozygous VPS39 knockout is embryonic lethal in mice, establishing non-redundant developmental essentiality; and epistasis in S. pombe confirmed evolutionary conservation of the Vam6–Gtr1–TORC1 axis.","evidence":"RILP-based Rab7-GTP pulldown and dominant-negative mutants in mammalian cells; knockout mouse embryonic lethality before E6.5; genetic epistasis in S. pombe","pmids":["20363736","20961651","22344254"],"confidence":"High","gaps":["Identity of the true mammalian Rab7 GEF unresolved","Mechanism of Rab7-independent lysosomal morphology control by VPS39 unknown","Cause of embryonic lethality not characterized at molecular level"]},{"year":2014,"claim":"Demonstration that VPS39 (via HOPS) interacts with the autophagosomal SNARE STX17 and is required for autophagosome–lysosome fusion established VPS39 as a central tethering factor in mammalian autophagy, resolving how autophagosomes are recognized by the lysosomal fusion machinery.","evidence":"siRNA knockdown, co-immunoprecipitation/mass spectrometry, autophagic flux assays in mammalian cells","pmids":["24554770"],"confidence":"High","gaps":["Structural basis of VPS39–STX17 interaction unknown","Whether VPS39 has autophagy functions independent of HOPS not addressed"]},{"year":2014,"claim":"Identification of hVps39-2/TRAP1 as a Rab5-GTP effector that co-localizes with early endosomes suggested it serves as the Vps3 equivalent in the human CORVET complex, distinguishing VPS39 isoform functions between HOPS and CORVET.","evidence":"In vitro Rab5-GTP binding, co-localization in HEK293 cells, yeast complementation","pmids":["25750764"],"confidence":"Medium","gaps":["Full reconstitution of human CORVET not achieved","Functional distinction between VPS39 isoforms in endosome maturation not fully resolved"]},{"year":2020,"claim":"Multiple studies revealed HOPS-independent functions of VPS39: it regulates phosphatidylethanolamine transport to mitochondria independent of the intact HOPS or vCLAMP complexes, and it negatively controls ciliogenesis through autophagy-dependent IFT20 localization, expanding VPS39 beyond endolysosomal tethering to organelle lipid homeostasis and ciliary biology.","evidence":"Lipid quantification (TLC, mass spectrometry) with genetic dissection in yeast; siRNA/morpholino knockdown with IFT20 immunofluorescence in human renal cells and medaka fish","pmids":["32058032","32077937"],"confidence":"Medium","gaps":["How VPS39 is recruited to mitochondrial membranes independently of HOPS is unknown","Whether PE transport and ciliogenesis functions are connected remains untested","Each function demonstrated by a single lab"]},{"year":2020,"claim":"SARS-CoV-2 ORF3a was shown to directly bind VPS39 and sequester it in late endosomes, blocking HOPS–STX17 and HOPS–RAB7 interactions to inhibit autophagosome–lysosome fusion, revealing VPS39 as a viral target for immune evasion and identifying a molecular basis for autophagy inhibition during COVID-19.","evidence":"Co-immunoprecipitation, SNARE assembly assays, RAB7–HOPS interaction assays, fluorescence co-localization, siRNA epistasis in SARS-CoV-2-infected cells","pmids":["33422265","33947832"],"confidence":"High","gaps":["Structural interface of ORF3a–VPS39 not resolved","Whether ORF3a targeting of VPS39 is sufficient for viral pathogenesis in vivo unknown"]},{"year":2021,"claim":"VPS39 downregulation in type 2 diabetic myoblasts was shown to impair autophagic flux, dysregulate epigenetic enzyme expression and DNA methylation at myogenic loci, and reduce muscle glucose uptake in heterozygous mice, linking VPS39 to metabolic disease through an autophagy–epigenetic coupling mechanism.","evidence":"siRNA knockdown in human primary myoblasts, RRBS, RNA-seq, autophagic flux assays, Vps39+/− mouse glucose uptake measurements","pmids":["33893273"],"confidence":"High","gaps":["Direct causal chain from autophagic flux to specific epigenetic changes not mechanistically resolved","Whether VPS39 variants contribute to T2D risk in humans not addressed"]},{"year":2022,"claim":"VPS39 was identified as a downstream effector of SGPL1 signaling that enhances mitochondria–lysosome membrane contact sites, establishing a second organelle-contact function for VPS39 beyond its yeast PE transport role and linking it to mitochondrial network maintenance under calcium stress.","evidence":"Quantitative proteomics, transcriptomics, biochemical fractionation, MCS imaging in MICU1-deficient mammalian cells and C. elegans","pmids":["35452878"],"confidence":"Medium","gaps":["Molecular determinants of VPS39 recruitment to MCS not defined","Whether HOPS-dependent and MCS functions are mutually exclusive is untested"]},{"year":2023,"claim":"ASFV protein CP204L was found to bind VPS39 and redirect it from the HOPS complex to virus factories, demonstrating that a second unrelated virus independently exploits VPS39 sequestration to reprogram endolysosomal trafficking for replication.","evidence":"Co-immunoprecipitation, proximity ligation, fluorescence colocalization, VPS39 knockout/knockdown with viral replication assays","pmids":["36722971"],"confidence":"Medium","gaps":["Whether CP204L and ORF3a bind overlapping VPS39 surfaces is unknown","Single lab; independent confirmation pending"]},{"year":null,"claim":"Key unresolved questions include the structural basis of VPS39 interactions with Rab GTPases, SNAREs, and viral proteins; how VPS39 is partitioned between HOPS-dependent fusion, HOPS-independent lipid transport, and membrane contact site functions; and whether VPS39's autophagy–epigenetic axis in muscle extends to other metabolic tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length VPS39 or VPS39 in complex with HOPS/RAB7/STX17","Molecular switch governing HOPS-dependent versus HOPS-independent VPS39 pools is uncharacterized","In vivo relevance of VPS39 in human metabolic disease requires genetic association data"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[1,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,5,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7,8]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[0,2,3,7,8]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[6,8,10]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[11,13]},{"term_id":"GO:0005773","term_label":"vacuole","supporting_discovery_ids":[0,1,2]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,2,7,8,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[7,8,9,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[11,15]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[12,13]}],"complexes":["HOPS complex","CORVET complex"],"partners":["VPS41","VPS33A","VPS16","STX17","RAB7","RAB5","GTR1","SGPL1"],"other_free_text":[]},"mechanistic_narrative":"VPS39 is a core subunit of the HOPS tethering complex that functions at the vacuole/lysosome to promote late endosome–lysosome and autophagosome–lysosome fusion by bridging RAB7 and the STX17–SNAP29–VAMP8 SNARE complex [PMID:9111041, PMID:24554770, PMID:33947832]. In yeast, Vps39 additionally acts as a guanine nucleotide exchange factor (GEF) for the Rag GTPase Gtr1, coupling vacuolar fusion machinery to TORC1 nutrient signaling [PMID:19748353, PMID:22344254], whereas mammalian VPS39 does not function as a Rab7 GEF but regulates lysosomal morphology and cell survival through a Rab7-GTP-independent mechanism [PMID:20363736]. Beyond its HOPS role, VPS39 participates in mitochondria–lysosome membrane contact sites to regulate phosphatidylethanolamine transport and BMP lipid biosynthesis independently of the intact HOPS complex [PMID:32058032, PMID:35452878], controls autophagy-dependent ciliogenesis and muscle stem cell differentiation with epigenetic consequences [PMID:32077937, PMID:33893273], and is directly targeted by viral proteins (SARS-CoV-2 ORF3a, ASFV CP204L) that sequester it to block autophagic flux and redirect endolysosomal trafficking [PMID:33422265, PMID:36722971]."},"prefetch_data":{"uniprot":{"accession":"Q96JC1","full_name":"Vam6/Vps39-like protein","aliases":["TRAP1-like protein","hVam6p"],"length_aa":886,"mass_kda":101.8,"function":"Regulator of TGF-beta/activin signaling, inhibiting SMAD3- and activating SMAD2-dependent transcription. Acts by interfering with SMAD3/SMAD4 complex formation, this would lead to inhibition of SMAD3-dependent transcription and relieve SMAD3 inhibition of SMAD2-dependent promoters, thus increasing SMAD2-dependent transcription. Does not affect TGF-beta-induced SMAD2 or SMAD3 phosphorylation, nor SMAD2/SMAD4 complex formation Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Acts as a component of the HOPS endosomal tethering complex. This complex is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the late endosomal membrane and to regulate late endocytic, phagocytic and autophagic traffic towards lysosomes (PubMed:23351085). Involved in homotypic vesicle fusions between late endosomes and in heterotypic fusions between late endosomes and lysosomes (PubMed:11448994, PubMed:23167963, PubMed:23351085). Required for fusion of endosomes and autophagosomes with lysosomes (PubMed:25783203, PubMed:37821429)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q96JC1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/VPS39","classification":"Not Classified","n_dependent_lines":200,"n_total_lines":1208,"dependency_fraction":0.16556291390728478},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000166887","cell_line_id":"CID001861","localizations":[{"compartment":"vesicles","grade":3},{"compartment":"cytoplasmic","grade":2}],"interactors":[{"gene":"RBM25","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001861","total_profiled":1310},"omim":[{"mim_id":"612188","title":"VPS39 SUBUNIT OF HOPS COMPLEX; VPS39","url":"https://www.omim.org/entry/612188"},{"mim_id":"610034","title":"VPS33A CORE SUBUNIT OF CORVET AND HOPS COMPLEXES; VPS33A","url":"https://www.omim.org/entry/610034"},{"mim_id":"608549","title":"VPS11 CORE SUBUNIT OF CORVET AND HOPS COMPLEXES; VPS11","url":"https://www.omim.org/entry/608549"},{"mim_id":"607623","title":"NPC INTRACELLULAR CHOLESTEROL TRANSPORTER 1; NPC1","url":"https://www.omim.org/entry/607623"},{"mim_id":"605419","title":"SCHIZOPHRENIA 10; SCZD10","url":"https://www.omim.org/entry/605419"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/VPS39"},"hgnc":{"alias_symbol":["KIAA0770","VAM6"],"prev_symbol":[]},"alphafold":{"accession":"Q96JC1","domains":[{"cath_id":"-","chopping":"2-46_257-311","consensus_level":"medium","plddt":90.9327,"start":2,"end":311}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JC1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96JC1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96JC1-F1-predicted_aligned_error_v6.png","plddt_mean":88.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=VPS39","jax_strain_url":"https://www.jax.org/strain/search?query=VPS39"},"sequence":{"accession":"Q96JC1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96JC1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96JC1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JC1"}},"corpus_meta":[{"pmid":"19748353","id":"PMC_19748353","title":"The Vam6 GEF controls TORC1 by activating the EGO complex.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19748353","citation_count":360,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9111041","id":"PMC_9111041","title":"Vam2/Vps41p and Vam6/Vps39p are components of a protein complex on the vacuolar membranes and involved in the vacuolar assembly in the yeast Saccharomyces cerevisiae.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9111041","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20363736","id":"PMC_20363736","title":"Differential effects of TBC1D15 and mammalian Vps39 on Rab7 activation state, lysosomal morphology, and growth factor dependence.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20363736","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22344254","id":"PMC_22344254","title":"The Vam6 and Gtr1-Gtr2 pathway activates TORC1 in response to amino acids in fission yeast.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22344254","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18077594","id":"PMC_18077594","title":"The zebrafish mutant lbk/vam6 resembles human multisystemic disorders caused by aberrant trafficking of endosomal vesicles.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18077594","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33893273","id":"PMC_33893273","title":"VPS39-deficiency observed in type 2 diabetes impairs muscle stem cell differentiation via altered autophagy and epigenetics.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33893273","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20961651","id":"PMC_20961651","title":"The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development.","date":"2010","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20961651","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25750764","id":"PMC_25750764","title":"The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET.","date":"2014","source":"Cellular logistics","url":"https://pubmed.ncbi.nlm.nih.gov/25750764","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32077937","id":"PMC_32077937","title":"The HOPS complex subunit VPS39 controls ciliogenesis through autophagy.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32077937","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36722971","id":"PMC_36722971","title":"CP204L Is a Multifunctional Protein of African Swine Fever Virus That Interacts with the VPS39 Subunit of the Homotypic Fusion and Vacuole Protein Sorting Complex and Promotes Lysosome Clustering.","date":"2023","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/36722971","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32058032","id":"PMC_32058032","title":"Vps39 is required for ethanolamine-stimulated elevation in mitochondrial phosphatidylethanolamine.","date":"2020","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/32058032","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19748348","id":"PMC_19748348","title":"Amino acid signaling to TOR activation: Vam6 functioning as a Gtr1 GEF.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19748348","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33478009","id":"PMC_33478009","title":"Vacuole and Mitochondria Patch (vCLAMP) Protein Vam6 Is Involved in Maintenance of Mitochondrial and Vacuolar Functions under Oxidative Stress in Candida albicans.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33478009","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35452878","id":"PMC_35452878","title":"SGPL1 stimulates VPS39 recruitment to the mitochondria in MICU1 deficient cells.","date":"2022","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35452878","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34072011","id":"PMC_34072011","title":"The Vacuolar Morphogenesis Protein Vam6-Like Protein Vlp1 Is Required for Pathogenicity of Cryptococcus neoformans.","date":"2021","source":"Journal of fungi (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34072011","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34057669","id":"PMC_34057669","title":"The Vacuole and Mitochondria Patch (vCLAMP) Protein Vam6 is Crucial for Autophagy in Candida albicans.","date":"2021","source":"Mycopathologia","url":"https://pubmed.ncbi.nlm.nih.gov/34057669","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34800311","id":"PMC_34800311","title":"Vam6/Vps39/TRAP1-domain proteins influence vacuolar morphology, iron acquisition and virulence in Cryptococcus neoformans.","date":"2021","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34800311","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36741382","id":"PMC_36741382","title":"Vam6 reduces iNKT cell function in tumor via modulating AMPK/mTOR pathways.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36741382","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36924104","id":"PMC_36924104","title":"Role of VPS39, a key tethering protein for endolysosomal trafficking and mitochondria-lysosome crosstalk, in health and disease.","date":"2023","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36924104","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39605369","id":"PMC_39605369","title":"SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39605369","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32724865","id":"PMC_32724865","title":"Non-native fold of the putative VPS39 zinc finger domain.","date":"2020","source":"Wellcome open research","url":"https://pubmed.ncbi.nlm.nih.gov/32724865","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39339953","id":"PMC_39339953","title":"Insights into the Role of VPS39 and Its Interaction with CP204L and A137R in ASFV Infection.","date":"2024","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/39339953","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41418320","id":"PMC_41418320","title":"Regulation of vacuole fusion in stomata by dephosphorylation of the HOPS subunit VPS39.","date":"2025","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/41418320","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39998208","id":"PMC_39998208","title":"The HOPS and vCLAMP protein Vam6 connects polyphosphate with mitochondrial function and oxidative stress resistance in Cryptococcus neoformans.","date":"2025","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/39998208","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41897552","id":"PMC_41897552","title":"Correction: Mao et al. Vacuole and Mitochondria Patch (vCLAMP) Protein Vam6 Is Involved in Maintenance of Mitochondrial and Vacuolar Functions Under Oxidative Stress in Candida albicans. Antioxidants 2021, 10, 136.","date":"2026","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/41897552","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32353859","id":"PMC_32353859","title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32353859","citation_count":3411,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26472760","id":"PMC_26472760","title":"Gene essentiality and synthetic lethality in haploid human cells.","date":"2015","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26472760","citation_count":657,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18552835","id":"PMC_18552835","title":"Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking.","date":"2008","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18552835","citation_count":629,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24554770","id":"PMC_24554770","title":"The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17.","date":"2014","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/24554770","citation_count":404,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33422265","id":"PMC_33422265","title":"ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.","date":"2020","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/33422265","citation_count":302,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32838362","id":"PMC_32838362","title":"Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.","date":"2020","source":"Med (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32838362","citation_count":291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25533187","id":"PMC_25533187","title":"mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25533187","citation_count":226,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33947832","id":"PMC_33947832","title":"The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes.","date":"2021","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/33947832","citation_count":203,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23022380","id":"PMC_23022380","title":"NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23022380","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34706264","id":"PMC_34706264","title":"ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress.","date":"2021","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/34706264","citation_count":165,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17897319","id":"PMC_17897319","title":"Integral and associated lysosomal membrane proteins.","date":"2007","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/17897319","citation_count":163,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11230166","id":"PMC_11230166","title":"Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.","date":"2001","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11230166","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29576527","id":"PMC_29576527","title":"Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29576527","citation_count":150,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36217030","id":"PMC_36217030","title":"A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.","date":"2022","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36217030","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12693,"output_tokens":3387,"usd":0.044442},"stage2":{"model":"claude-opus-4-6","input_tokens":6797,"output_tokens":2887,"usd":0.15924},"total_usd":0.471803,"stage1_batch_id":"msgbatch_01BparvgRZ9S2LMidvaoo86K","stage2_batch_id":"msgbatch_01NkBfv9SVZWthhS7j6mU6G3","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":25732,"output_tokens":4508,"usd":0.072408},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8225,"output_tokens":3574,"usd":0.195713}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Vam6/Vps39 (yeast) physically interacts with Vam2/Vps41, forming a protein complex on vacuolar membranes required for vacuolar assembly and proper sorting of vacuolar proteins including CPY, proteinase A, proteinase B, carboxypeptidase Y, and alkaline phosphatase\",\n      \"method\": \"Chemical cross-linking, co-fractionation, epitope-tagging, GFP localization, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (cross-linking, fractionation, GFP imaging, functional assays) in a single study\",\n      \"pmids\": [\"9111041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Yeast Vam6/Vps39 functions as a guanine nucleotide exchange factor (GEF) for the Rag GTPase homolog Gtr1, loading GTP onto Gtr1 to activate the EGO complex and thereby promote TORC1 activation in an amino-acid-sensitive manner\",\n      \"method\": \"Genetic epistasis, GTPase nucleotide-state mutants, TORC1 activity assays, co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis plus biochemical GEF assay, high citation count, replicated in fission yeast\",\n      \"pmids\": [\"19748353\", \"19748348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In fission yeast, Vam6 functions upstream of Gtr1/Gtr2 (Rag GTPases) and upstream of TORC1 in an amino-acid-sensing pathway, as established by genetic epistasis analysis\",\n      \"method\": \"Genetic epistasis, deletion mutants, mating/sporulation phenotype readouts, co-localization\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis in fission yeast ortholog, single lab\",\n      \"pmids\": [\"22344254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mammalian Vps39 (mVps39) induces lysosomal clustering independent of increasing Rab7-GTP levels; a dominant-negative mVps39 mutant fragments lysosomes and promotes growth factor independence without decreasing Rab7-GTP, indicating mVps39 is not the Rab7 GEF\",\n      \"method\": \"Effector pulldown assay (RILP-based Rab7-GTP measurement), dominant-negative overexpression, lysosomal morphology imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct GTPase activity assay plus cellular morphology readout, single lab\",\n      \"pmids\": [\"20363736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss of vam6/vps39 function in zebrafish (lbk mutant) causes defective vesicle tethering and fusion, resulting in enlarged intracellular vesicles in RPE, liver, intestine, and macrophages, establishing Vam6 as an essential HOPS component for vesicle tethering/fusion in a multicellular organism\",\n      \"method\": \"Positional cloning, allele screen, rescue experiments, morpholino knockdown, electron microscopy of vesicle morphology\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic approaches (rescue, morpholino, allele screen) with defined cellular phenotype\",\n      \"pmids\": [\"18077594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Human Vps39-2/TRAP1 co-localizes with Rab5 and directly interacts with Rab5-GTP in vitro, functioning as an effector of Rab5 and likely representing the missing Vps3 subunit of the human CORVET complex\",\n      \"method\": \"In vitro pulldown with GTP-locked Rab5, co-localization in mammalian cells, yeast complementation assay\",\n      \"journal\": \"Cellular logistics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro direct binding assay plus cellular co-localization, single lab\",\n      \"pmids\": [\"25750764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"VPS39, as a subunit of the HOPS complex, acts as a negative regulator of ciliogenesis in human renal cells by controlling the localization of IFT20 at the base of cilia through autophagy; this was also validated in renal tubules of medaka fish in vivo\",\n      \"method\": \"VPS39 knockdown in human renal cells, IFT20 localization assay, autophagy modulation, in vivo medaka fish model\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined mechanistic readout (IFT20 mislocalization) in two systems, single lab\",\n      \"pmids\": [\"32077937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Yeast Vps39 plays a specific role in phosphatidylethanolamine (PE) transport to mitochondria; deletion of Vps39 prevents ethanolamine-stimulated elevation of mitochondrial PE levels without affecting PE biosynthesis in the ER or PE transport to other organelles, and Vps39 abundance and recruitment to mitochondria/ER depends on PE levels in those organelles\",\n      \"method\": \"Genetic deletion, lipid quantification, subcellular fractionation, organelle PE measurement\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic deletion with specific lipid transport readout and organelle fractionation, single lab\",\n      \"pmids\": [\"32058032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"VPS39 knockdown in human myoblasts impairs autophagic flux, insulin signaling, and epigenetic reprogramming, leading to dysregulation of myogenic regulators and perturbed differentiation; Vps39+/- mice display reduced muscle glucose uptake\",\n      \"method\": \"siRNA knockdown in human myoblasts, autophagic flux assay, insulin signaling assay, DNA methylation analysis, mouse genetic model with glucose uptake measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (autophagic flux, signaling, epigenetics, mouse model), Strong evidence\",\n      \"pmids\": [\"33893273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"VPS39 is essential for early embryonic development in mice; homozygous VPS39 knockout results in lethality before E6.5, demonstrating a non-redundant in vivo role\",\n      \"method\": \"Mouse knockout, embryonic lethality staging\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined developmental phenotype, single lab\",\n      \"pmids\": [\"20961651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SGPL1 upregulation stimulates VPS39 recruitment to mitochondria, enhancing mitochondria-lysosome membrane contact sites (MCS); VPS39 downregulation compromises mitochondrial network maintenance and basal autophagic flux in MICU1-deficient cells; VPS39 recruitment to mitochondria is a signature associated with altered OXPHOS\",\n      \"method\": \"Transcriptomics, quantitative proteomics, biochemical fractionation, imaging of mitochondria-lysosome contacts, C. elegans lifespan assay, mammalian cell knockdown\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cross-species validation with multiple orthogonal methods, single lab\",\n      \"pmids\": [\"35452878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ASFV protein CP204L binds VPS39, blocking its association with the lysosomal HOPS complex and redirecting VPS39 to viral factories; loss of VPS39 reduces early viral protein synthesis and delays ASFV replication\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation, VPS39 knockdown with viral replication readout, confocal localization\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction assays plus functional KD phenotype, single lab\",\n      \"pmids\": [\"36722971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Vam6/VPS39 in iNKT cells forms a Rab7a-Vam6-AMPK complex that recruits AMPK to lysosomes to activate AMPK (a negative regulator of mTORC1); VDAC1 inhibits this complex formation at mitochondria-lysosome contact sites; lactic acid from tumor cells increases Vam6 expression, impairing mTORC1 and IFN-γ production\",\n      \"method\": \"Co-immunoprecipitation, flow cytometry, RNA sequencing, Vam6 conditional knockout mice, lysosome fractionation\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — complex formation by co-IP plus genetic KO with defined signaling readout, single lab\",\n      \"pmids\": [\"36741382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Crystal structure of the VPS39 C-terminal putative zinc finger domain was solved; however, the domain adopts a non-native fold (anti-parallel β-hairpin in a homotetrameric β-barrel) stabilized by tag-mediated zinc coordination and an intramolecular disulphide, indicating that the native structure of this domain remains unresolved\",\n      \"method\": \"Recombinant expression, purification, X-ray crystallography\",\n      \"journal\": \"Wellcome open research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 1 method but non-native fold — no functional validation of the structure\",\n      \"pmids\": [\"32724865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SARS-CoV-2 ORF3a binds VPS39 and disrupts its function in two ways: (1) trapping CI-MPR and retromer in endosomes/lysosomes to impair NPC2 trafficking, and (2) reducing lysosome-mitochondrion MCS and BMP (bis(monoacylglycerol)phosphate) levels required for cholesterol export; VPS39 deletion alone decreased MCS and BMPs, identifying VPS39 as a regulator of NPC2 trafficking and BMP biosynthesis\",\n      \"method\": \"Co-immunoprecipitation, lipidomics, proteomics, VPS39 deletion, retromer deletion, cholesterol trafficking assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (lipidomics, proteomics, genetic deletion) but preprint\",\n      \"pmids\": [\"39605369\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"VPS39 (Vam6) is a core subunit of the HOPS tethering complex on late endosomal/lysosomal membranes that directly interacts with Vps41/Vam2 and mediates vesicle tethering and fusion; it also functions as a GEF for the Rag GTPase Gtr1/RagA to activate TORC1/mTORC1 in response to amino acids, recruits to mitochondria-lysosome membrane contact sites to regulate phosphatidylethanolamine transport and autophagic flux, controls lysosomal morphology and NPC2/cholesterol trafficking, and in mammals regulates muscle stem cell differentiation, ciliogenesis via autophagy, and early embryonic development.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Vam6/Vps39 (123 kDa) and Vam2/Vps41 physically interact and co-exist as components of a large protein complex on vacuolar membranes in S. cerevisiae. Loss of either protein causes accumulation of small vacuole-related structures (~200–400 nm), inefficient processing of vacuolar proteases (proteinase A, B, carboxypeptidase Y, alkaline phosphatase), and missortng of CPY to the cell surface, establishing their role in vacuolar assembly.\",\n      \"method\": \"Chemical cross-linking, co-fractionation, GFP-tagging with live imaging, density gradient fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-fractionation, cross-linking, GFP localization with defined loss-of-function phenotypes; foundational paper replicated widely\",\n      \"pmids\": [\"9111041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Yeast Vam6/Vps39 functions as a guanine nucleotide exchange factor (GEF) for the Rag GTPase homolog Gtr1, loading it with GTP to activate TORC1 in response to amino acids. GTP-bound Gtr1 interacts strongly with TORC1, and Vam6 thereby connects its established role in vacuolar fusion (HOPS complex) to nutrient-sensitive TORC1 regulation via the EGO complex.\",\n      \"method\": \"GTP-binding assays, constitutively active/dominant-negative Gtr1 mutant expression, TORC1 activity assays, co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — GEF activity demonstrated with nucleotide-binding mutants and TORC1 activity readouts; replicated across two labs in same issue\",\n      \"pmids\": [\"19748353\", \"19748348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss of zebrafish vam6/vps39 (lbk mutant) causes hypopigmentation of melanocytes and RPE, absence of iridophore reflections, defects in liver, intestine, vision, and macrophage function, with accumulation of enlarged intracellular vesicles in affected cells. Positional cloning, allele screening, rescue experiments, and morpholino knockdown confirm vam6/vps39 as causative, establishing its essential role in HOPS-mediated vesicle tethering and fusion in a multicellular organism.\",\n      \"method\": \"Positional cloning, rescue experiments, morpholino knockdown, electron microscopy, behavioral/physiological assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo methods (cloning, rescue, morpholino) with defined cellular phenotypes\",\n      \"pmids\": [\"18077594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Mammalian Vps39 (mVps39) induces lysosomal clustering when overexpressed, but contrary to expectation for a Rab7 GEF, does not increase Rab7-GTP levels as measured by RILP effector pulldown. A dominant-negative mVps39 mutant fragments lysosomes and promotes growth factor independence without reducing Rab7-GTP, indicating that mVps39 regulates lysosomal morphology and cell survival via a Rab7-GTP-independent mechanism and is not the bona fide Rab7 GEF.\",\n      \"method\": \"Effector pulldown assay (RILP-based Rab7 activation), dominant-negative mutant expression, lysosome morphology imaging, cell death assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct GTPase activity measurement with effector pulldown plus dominant-negative genetics; multiple orthogonal readouts\",\n      \"pmids\": [\"20363736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"VPS39 (also known as TLP/TRAP1-Like-Protein) is essential for early mouse embryonic development; homozygous VPS39-knockout mice die before E6.5, demonstrating a non-redundant in vivo requirement distinct from the paralog TRAP1.\",\n      \"method\": \"Knockout mouse generation, embryonic lethal phenotype analysis\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined developmental phenotype; single study\",\n      \"pmids\": [\"20961651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In fission yeast (S. pombe), Vam6 functions upstream of Gtr1/Gtr2 (Rag GTPase homologs) and upstream of TORC1 in an amino-acid-sensing pathway. Epistasis analysis places Vam6 as the upstream activator in the Vam6–Gtr1/Gtr2–TORC1 axis that promotes cell growth and inhibits sexual differentiation, confirming evolutionary conservation of this signaling pathway.\",\n      \"method\": \"Genetic epistasis analysis, deletion mutants, colocalization imaging, mating/sporulation phenotype assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in an orthologous organism with multiple phenotypic readouts; single lab\",\n      \"pmids\": [\"22344254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Human CORVET lacks a defined Vps3 subunit; hVps39-2/TRAP1 (a VPS39 isoform) co-localizes with Rab5-positive endosomes and directly binds Rab5-GTP in vitro, identifying it as an effector of Rab5 and the likely Vps3 subunit of the human CORVET complex.\",\n      \"method\": \"In vitro Rab5-GTP binding assay, co-localization imaging in HEK293 cells and yeast, yeast complementation\",\n      \"journal\": \"Cellular logistics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct in vitro binding plus cellular co-localization; single lab\",\n      \"pmids\": [\"25750764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"VPS39 (as a component of the HOPS complex) is required for autophagosome-lysosome fusion in mammalian cells. VPS39 knockdown blocks autophagic flux and causes accumulation of STX17/LC3-positive autophagosomes. HOPS interacts with the autophagosomal SNARE STX17 (co-precipitated via VPS33A/VPS16/VPS39), linking VPS39 to the STX17–SNAP29–VAMP8 SNARE assembly needed for fusion.\",\n      \"method\": \"siRNA knockdown, immunoprecipitation/mass spectrometry, autophagic flux assays, fluorescence microscopy\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, knockdown with defined autophagic flux phenotype; replicated in multiple subsequent studies\",\n      \"pmids\": [\"24554770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SARS-CoV-2 ORF3a directly interacts with VPS39, sequestering it in late endosomes, which prevents the HOPS complex from interacting with the autophagosomal SNARE protein STX17, thus blocking assembly of the STX17–SNAP29–VAMP8 SNARE complex required for autophagosome/lysosome fusion and leading to accumulation of unfused autophagosomes. SARS-CoV ORF3a does not interact with HOPS/VPS39.\",\n      \"method\": \"Co-immunoprecipitation, autophagosome-lysosome fusion assays, fluorescence co-localization, siRNA knockdown, SARS-CoV-2 infection\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding, SNARE complex assembly assays, knockdown epistasis, infection context; multiple orthogonal approaches\",\n      \"pmids\": [\"33422265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"VPS39 is downregulated in myoblasts and myotubes from individuals with type 2 diabetes. VPS39 knockdown in human myoblasts impairs autophagic flux, dysregulates insulin signaling, alters epigenetic enzyme expression and DNA methylation at myogenic regulator loci, and perturbs differentiation. Vps39+/− mice display reduced muscle glucose uptake and altered expression of genes involved in autophagy, epigenetic programming, and myogenesis.\",\n      \"method\": \"siRNA knockdown in human myoblasts, RRBS DNA methylation, RNA-seq, autophagic flux assays, heterozygous mouse model with glucose uptake measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in human primary cells and mouse model with multiple orthogonal molecular and metabolic readouts\",\n      \"pmids\": [\"33893273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SARS-CoV-2 ORF3a interacts with VPS39 and prevents binding of HOPS to RAB7, blocking the assembly of fusion machinery and causing accumulation of unfused autophagosomes, consistent with VPS39 being the critical HOPS subunit bridging RAB7 interaction for autophagosome–lysosome fusion.\",\n      \"method\": \"Co-immunoprecipitation, autophagosome-lysosome fusion assays, RAB7-HOPS interaction assays, fluorescence microscopy\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and epistasis; largely corroborates Miao et al. 2020 findings\",\n      \"pmids\": [\"33947832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Yeast Vps39 has a specific role in phosphatidylethanolamine (PE) transport to the mitochondria. Deletion of VPS39 prevents ethanolamine-stimulated elevation of mitochondrial PE without affecting PE biosynthesis in the ER or PE transport to other organelles. Vps39 abundance and its recruitment to mitochondria and ER is regulated by local PE levels, and this function is independent of the intact HOPS or vCLAMP complexes.\",\n      \"method\": \"Lipid extraction and quantification (TLC, mass spectrometry), subcellular fractionation, genetic deletion of complex subunits, ethanolamine-labeling experiments\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — lipid quantification with genetic dissection of complex independence; single lab\",\n      \"pmids\": [\"32058032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"VPS39 controls ciliogenesis in human renal cells by regulating the localization of IFT20 (intraflagellar transport 20) at the base of cilia through autophagy. VPS39 acts as a negative regulator of ciliogenesis, and this function is conserved in vivo in medaka fish renal tubules.\",\n      \"method\": \"siRNA knockdown in human renal cells, morpholino knockdown in medaka, autophagy modulation, immunofluorescence of IFT20 localization, cilia length/number quantification\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in cells and in vivo model with defined localization phenotype and pathway (autophagy) link; single lab\",\n      \"pmids\": [\"32077937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SGPL1 (sphingosine-1-phosphate lyase) upregulation stimulates VPS39 recruitment to the mitochondria, enhancing mitochondria-lysosome membrane contact sites (MCS). VPS39 downregulation compromises mitochondrial network maintenance and basal autophagic flux in MICU1-deficient cells, placing VPS39 as a key effector in SGPL1-mediated organelle interaction and autophagy sustenance.\",\n      \"method\": \"Quantitative proteomics, transcriptomics, biochemical fractionation, imaging of MCS, VPS39 knockdown, MICU1-deficient C. elegans and mammalian cell models\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omics plus functional validation across species; single lab\",\n      \"pmids\": [\"35452878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ASFV protein CP204L binds VPS39 and blocks its association with the lysosomal HOPS complex, redirecting CP204L-VPS39 complexes to virus factories. Loss of VPS39 reduces early viral protein synthesis and delays ASFV replication, demonstrating that VPS39 is exploited by ASFV for early replication steps and is involved in endolysosomal trafficking during infection.\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation, fluorescence colocalization, VPS39 knockout/knockdown, viral replication assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding, knockout phenotype in viral context; single lab\",\n      \"pmids\": [\"36722971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SARS-CoV-2 ORF3a binds VPS39 and through this interaction: (1) traps the CI-MPR sorting receptor and retromer complex in endosomes/lysosomes, impairing NPC2 cholesterol transporter trafficking; and (2) reduces bis(monoacylglycerol)phosphate (BMP) lipids required for cholesterol export by decreasing lysosome-mitochondrion membrane contact sites (MCS). VPS39 deletion alone decreases MCS and BMPs, identifying VPS39 as a regulator of NPC2 trafficking and BMP biosynthesis.\",\n      \"method\": \"Lipidomics, proteomics, retromer deletion epistasis, MCS quantification, NPC2 trafficking assays, cholesterol efflux assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (lipidomics, proteomics, epistasis, MCS imaging); preprint, not yet peer-reviewed\",\n      \"pmids\": [\"39605369\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Crystal structure of the C-terminal putative zinc finger domain of VPS39 was solved, revealing it adopts a non-native anti-parallel β-hairpin fold incorporated into a homotetrameric eight-stranded β-barrel under the recombinant conditions used, stabilized by tag-mediated zinc coordination and an intramolecular disulfide bond rather than the expected zinc finger fold.\",\n      \"method\": \"Recombinant protein expression, X-ray crystallography\",\n      \"journal\": \"Wellcome open research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 1 method but result is explicitly non-native fold; finding is a cautionary structural observation rather than functional mechanistic insight\",\n      \"pmids\": [\"32724865\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"VPS39 is a core subunit of the HOPS tethering complex that resides on vacuolar/lysosomal membranes, where it promotes late endosome–lysosome and autophagosome–lysosome fusion (via interaction with STX17-containing SNARE complexes and RAB7), and in yeast additionally functions as a GEF for the Rag GTPase Gtr1 to activate TORC1 in response to amino acids; beyond its canonical HOPS role, VPS39 independently participates in mitochondria–lysosome membrane contact sites to regulate phosphatidylethanolamine transport and BMP biosynthesis, is required for muscle stem cell differentiation and glucose uptake through autophagy-epigenetic coupling, and is exploited by viral proteins (SARS-CoV-2 ORF3a, ASFV CP204L) that sequester VPS39 to block autophagic flux or redirect endolysosomal trafficking.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"VPS39 is a core subunit of the HOPS tethering complex that mediates late endosomal/lysosomal vesicle tethering and fusion, with conserved roles from yeast to vertebrates in vacuolar/lysosomal biogenesis and cargo sorting [PMID:9111041, PMID:18077594]. Beyond its structural role in HOPS, VPS39 functions as a guanine nucleotide exchange factor (GEF) for the Rag family GTPase Gtr1, thereby activating TORC1 signaling in response to amino acids [PMID:19748353, PMID:22344254], and it scaffolds a Rab7a–AMPK complex on lysosomes to regulate mTORC1 activity in mammalian immune cells [PMID:36741382]. VPS39 also localizes to mitochondria–lysosome membrane contact sites where it regulates phosphatidylethanolamine transport, BMP biosynthesis, NPC2/cholesterol trafficking, and basal autophagic flux, linking it to mitochondrial network maintenance and OXPHOS adaptation [PMID:32058032, PMID:35452878, PMID:33893273]. Homozygous VPS39 knockout in mice causes embryonic lethality before E6.5, and VPS39 haploinsufficiency impairs muscle glucose uptake and myoblast differentiation, underscoring its non-redundant role in mammalian development and metabolic homeostasis [PMID:20961651, PMID:33893273].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Identifying VPS39 as a physical partner of VPS41 on vacuolar membranes established it as a component of the machinery required for vacuolar protein sorting and assembly, answering the question of which factors mediate vacuolar biogenesis.\",\n      \"evidence\": \"Chemical cross-linking, co-fractionation, GFP localization, and functional sorting assays in S. cerevisiae\",\n      \"pmids\": [\"9111041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No biochemical activity assigned to VPS39 itself\",\n        \"Stoichiometry and full composition of the complex not yet defined\",\n        \"Mechanism of membrane recruitment unknown\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Positional cloning of the zebrafish lbk mutant demonstrated that VPS39/Vam6 is an essential HOPS component for vesicle tethering and fusion in a multicellular organism, extending the yeast model to vertebrate cell biology.\",\n      \"evidence\": \"Positional cloning, rescue experiments, morpholino knockdown, and EM in zebrafish\",\n      \"pmids\": [\"18077594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Tissue-specific requirements in mammals not yet tested\",\n        \"Distinction between VPS39's tethering role and possible signaling roles not addressed\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that VPS39/Vam6 acts as a GEF for the Rag GTPase Gtr1, loading GTP to activate TORC1 in response to amino acids, revealed a dual function for VPS39 linking membrane trafficking to nutrient signaling.\",\n      \"evidence\": \"Genetic epistasis, nucleotide-state mutants, TORC1 activity assays, and co-immunoprecipitation in budding and fission yeast\",\n      \"pmids\": [\"19748353\", \"19748348\", \"22344254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the GEF activity is conserved in mammalian VPS39 was not established\",\n        \"Structural basis of GEF activity unknown\",\n        \"Whether HOPS complex membership is required for GEF function unclear\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstration that mammalian VPS39 promotes lysosomal clustering without increasing Rab7-GTP levels clarified that VPS39 is not the Rab7 GEF and functions through a distinct mechanism in lysosome positioning.\",\n      \"evidence\": \"Rab7-GTP effector pulldown assay and dominant-negative VPS39 overexpression in mammalian cells\",\n      \"pmids\": [\"20363736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The direct mechanism by which VPS39 promotes lysosomal clustering remains undefined\",\n        \"Role of other HOPS subunits in this phenotype not dissected\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Multiple discoveries in 2020 expanded VPS39's roles beyond vesicle fusion: (1) regulation of phosphatidylethanolamine transport to mitochondria, (2) negative regulation of ciliogenesis via autophagy-dependent IFT20 mislocalization, and (3) an initial (non-native) crystal structure of its C-terminal domain.\",\n      \"evidence\": \"Yeast deletion with organelle lipid quantification; VPS39 KD in human renal cells with IFT20 imaging and in vivo medaka validation; X-ray crystallography of C-terminal domain\",\n      \"pmids\": [\"32058032\", \"32077937\", \"32724865\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Native structure of the C-terminal zinc-finger domain remains unresolved (crystallized fold was artifactual)\",\n        \"Whether PE transport function is HOPS-dependent or independent is unknown\",\n        \"Mechanism linking autophagy to IFT20 localization via VPS39 is indirect\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"VPS39 was shown to be essential for mouse embryonic development (KO lethal before E6.5) and required for autophagic flux, insulin signaling, and myogenic differentiation in human myoblasts, establishing its non-redundant role in mammalian physiology.\",\n      \"evidence\": \"Mouse VPS39 KO with embryonic lethality staging; siRNA KD in human myoblasts with autophagy, signaling, and epigenetic assays; Vps39+/- mice with muscle glucose uptake measurement\",\n      \"pmids\": [\"20961651\", \"33893273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis of embryonic lethality not characterized\",\n        \"Whether muscle phenotypes reflect HOPS dysfunction, TORC1 signaling, or lipid transport is unresolved\",\n        \"Conditional tissue-specific KO analyses needed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"VPS39 recruitment to mitochondria downstream of SGPL1 was shown to enhance mitochondria–lysosome membrane contact sites and support basal autophagic flux, linking VPS39 to OXPHOS adaptation and mitochondrial network maintenance.\",\n      \"evidence\": \"Transcriptomics, proteomics, biochemical fractionation, mitochondria–lysosome contact imaging in MICU1-deficient mammalian cells, and C. elegans lifespan assays\",\n      \"pmids\": [\"35452878\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct molecular interaction mediating VPS39 tethering at mitochondria–lysosome MCS not identified\",\n        \"Cross-species validation in C. elegans used a lifespan endpoint, not direct VPS39 function\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Two studies revealed that VPS39 is targeted by pathogens and functions as a lysosomal signaling scaffold: ASFV protein CP204L sequesters VPS39 away from HOPS to benefit viral replication, while in iNKT cells VPS39 scaffolds a Rab7a–AMPK complex on lysosomes to activate AMPK and restrain mTORC1.\",\n      \"evidence\": \"Co-IP, proximity ligation, and VPS39 KD with ASFV replication readout; co-IP, conditional KO, and lysosome fractionation in iNKT cells\",\n      \"pmids\": [\"36722971\", \"36741382\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural basis of CP204L–VPS39 interaction not defined\",\n        \"Whether AMPK scaffolding is a general VPS39 function or specific to iNKT cells is unknown\",\n        \"Role of VDAC1 inhibition of the Rab7a–Vam6–AMPK complex needs independent confirmation\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the native high-resolution structure of VPS39, whether its Rag GTPase GEF activity is conserved in mammals, how VPS39 is partitioned between HOPS-dependent vesicle fusion and HOPS-independent functions (lipid transport, AMPK scaffolding), and the molecular basis of its mitochondria–lysosome MCS tethering activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No native full-length or domain structure available\",\n        \"Mammalian GEF activity toward RagA/B not biochemically demonstrated\",\n        \"Mechanism of VPS39 recruitment to mitochondria–lysosome contact sites undefined\",\n        \"Separation-of-function mutants distinguishing HOPS-dependent from independent roles not reported\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0060090\",\n        \"supporting_discovery_ids\": [0, 12]\n      },\n      {\n        \"term_id\": \"GO:0098772\",\n        \"supporting_discovery_ids\": [1, 2]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005764\",\n        \"supporting_discovery_ids\": [0, 3, 4, 6, 12]\n      },\n      {\n        \"term_id\": \"GO:0005739\",\n        \"supporting_discovery_ids\": [7, 10]\n      },\n      {\n        \"term_id\": \"GO:0005768\",\n        \"supporting_discovery_ids\": [5]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-5653656\",\n        \"supporting_discovery_ids\": [0, 4, 6]\n      },\n      {\n        \"term_id\": \"R-HSA-9612973\",\n        \"supporting_discovery_ids\": [6, 8, 10]\n      },\n      {\n        \"term_id\": \"R-HSA-162582\",\n        \"supporting_discovery_ids\": [1, 2, 12]\n      },\n      {\n        \"term_id\": \"R-HSA-1430728\",\n        \"supporting_discovery_ids\": [7, 14]\n      }\n    ],\n    \"complexes\": [\n      \"HOPS complex\",\n      \"Rab7a-Vam6-AMPK complex\"\n    ],\n    \"partners\": [\n      \"VPS41\",\n      \"RAB7A\",\n      \"GTR1\",\n      \"RAB5\",\n      \"PRKAA1\",\n      \"CP204L\",\n      \"SGPL1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"VPS39 is a core subunit of the HOPS tethering complex that functions at the vacuole/lysosome to promote late endosome–lysosome and autophagosome–lysosome fusion by bridging RAB7 and the STX17–SNAP29–VAMP8 SNARE complex [PMID:9111041, PMID:24554770, PMID:33947832]. In yeast, Vps39 additionally acts as a guanine nucleotide exchange factor (GEF) for the Rag GTPase Gtr1, coupling vacuolar fusion machinery to TORC1 nutrient signaling [PMID:19748353, PMID:22344254], whereas mammalian VPS39 does not function as a Rab7 GEF but regulates lysosomal morphology and cell survival through a Rab7-GTP-independent mechanism [PMID:20363736]. Beyond its HOPS role, VPS39 participates in mitochondria–lysosome membrane contact sites to regulate phosphatidylethanolamine transport and BMP lipid biosynthesis independently of the intact HOPS complex [PMID:32058032, PMID:35452878], controls autophagy-dependent ciliogenesis and muscle stem cell differentiation with epigenetic consequences [PMID:32077937, PMID:33893273], and is directly targeted by viral proteins (SARS-CoV-2 ORF3a, ASFV CP204L) that sequester it to block autophagic flux and redirect endolysosomal trafficking [PMID:33422265, PMID:36722971].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of Vam6/Vps39 as a vacuolar membrane protein that physically associates with Vam2/Vps41 in a large complex essential for vacuolar assembly established VPS39 as a tethering/fusion factor rather than a sorting receptor or protease.\",\n      \"evidence\": \"Chemical cross-linking, co-fractionation, GFP imaging, and vacuolar protease processing assays in S. cerevisiae\",\n      \"pmids\": [\"9111041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Complete subunit composition of the complex not yet defined\",\n        \"Mechanism of membrane tethering unknown\",\n        \"No metazoan homolog characterized\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Positional cloning of the zebrafish leberknödel mutant demonstrated that VPS39 is essential for HOPS-dependent vesicle fusion in a multicellular organism, extending its role beyond yeast vacuolar biogenesis to pigmentation, liver, intestine, and immune cell function.\",\n      \"evidence\": \"Positional cloning, rescue, morpholino knockdown, electron microscopy in zebrafish\",\n      \"pmids\": [\"18077594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mammalian in vivo requirement not yet established\",\n        \"Which HOPS subunit interactions are conserved in vertebrates remains undefined\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that yeast Vam6/Vps39 acts as a GEF for the Rag GTPase Gtr1 to activate TORC1 revealed that VPS39 links vacuolar fusion to nutrient signaling, answering how amino acid availability is communicated to the growth-control machinery at the vacuolar surface.\",\n      \"evidence\": \"GTP-binding assays, constitutively active/dominant-negative Gtr1 mutants, TORC1 activity readouts, co-immunoprecipitation in S. cerevisiae\",\n      \"pmids\": [\"19748353\", \"19748348\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the GEF activity is conserved in mammalian VPS39 was untested\",\n        \"Structural basis of the GEF mechanism unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Three findings collectively refined VPS39 biology in mammals: mammalian VPS39 does not function as a Rab7 GEF yet regulates lysosomal morphology and cell survival through a GTP-independent mechanism; homozygous VPS39 knockout is embryonic lethal in mice, establishing non-redundant developmental essentiality; and epistasis in S. pombe confirmed evolutionary conservation of the Vam6–Gtr1–TORC1 axis.\",\n      \"evidence\": \"RILP-based Rab7-GTP pulldown and dominant-negative mutants in mammalian cells; knockout mouse embryonic lethality before E6.5; genetic epistasis in S. pombe\",\n      \"pmids\": [\"20363736\", \"20961651\", \"22344254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the true mammalian Rab7 GEF unresolved\",\n        \"Mechanism of Rab7-independent lysosomal morphology control by VPS39 unknown\",\n        \"Cause of embryonic lethality not characterized at molecular level\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstration that VPS39 (via HOPS) interacts with the autophagosomal SNARE STX17 and is required for autophagosome–lysosome fusion established VPS39 as a central tethering factor in mammalian autophagy, resolving how autophagosomes are recognized by the lysosomal fusion machinery.\",\n      \"evidence\": \"siRNA knockdown, co-immunoprecipitation/mass spectrometry, autophagic flux assays in mammalian cells\",\n      \"pmids\": [\"24554770\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of VPS39–STX17 interaction unknown\",\n        \"Whether VPS39 has autophagy functions independent of HOPS not addressed\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of hVps39-2/TRAP1 as a Rab5-GTP effector that co-localizes with early endosomes suggested it serves as the Vps3 equivalent in the human CORVET complex, distinguishing VPS39 isoform functions between HOPS and CORVET.\",\n      \"evidence\": \"In vitro Rab5-GTP binding, co-localization in HEK293 cells, yeast complementation\",\n      \"pmids\": [\"25750764\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Full reconstitution of human CORVET not achieved\",\n        \"Functional distinction between VPS39 isoforms in endosome maturation not fully resolved\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Multiple studies revealed HOPS-independent functions of VPS39: it regulates phosphatidylethanolamine transport to mitochondria independent of the intact HOPS or vCLAMP complexes, and it negatively controls ciliogenesis through autophagy-dependent IFT20 localization, expanding VPS39 beyond endolysosomal tethering to organelle lipid homeostasis and ciliary biology.\",\n      \"evidence\": \"Lipid quantification (TLC, mass spectrometry) with genetic dissection in yeast; siRNA/morpholino knockdown with IFT20 immunofluorescence in human renal cells and medaka fish\",\n      \"pmids\": [\"32058032\", \"32077937\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"How VPS39 is recruited to mitochondrial membranes independently of HOPS is unknown\",\n        \"Whether PE transport and ciliogenesis functions are connected remains untested\",\n        \"Each function demonstrated by a single lab\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"SARS-CoV-2 ORF3a was shown to directly bind VPS39 and sequester it in late endosomes, blocking HOPS–STX17 and HOPS–RAB7 interactions to inhibit autophagosome–lysosome fusion, revealing VPS39 as a viral target for immune evasion and identifying a molecular basis for autophagy inhibition during COVID-19.\",\n      \"evidence\": \"Co-immunoprecipitation, SNARE assembly assays, RAB7–HOPS interaction assays, fluorescence co-localization, siRNA epistasis in SARS-CoV-2-infected cells\",\n      \"pmids\": [\"33422265\", \"33947832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural interface of ORF3a–VPS39 not resolved\",\n        \"Whether ORF3a targeting of VPS39 is sufficient for viral pathogenesis in vivo unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"VPS39 downregulation in type 2 diabetic myoblasts was shown to impair autophagic flux, dysregulate epigenetic enzyme expression and DNA methylation at myogenic loci, and reduce muscle glucose uptake in heterozygous mice, linking VPS39 to metabolic disease through an autophagy–epigenetic coupling mechanism.\",\n      \"evidence\": \"siRNA knockdown in human primary myoblasts, RRBS, RNA-seq, autophagic flux assays, Vps39+/− mouse glucose uptake measurements\",\n      \"pmids\": [\"33893273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct causal chain from autophagic flux to specific epigenetic changes not mechanistically resolved\",\n        \"Whether VPS39 variants contribute to T2D risk in humans not addressed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"VPS39 was identified as a downstream effector of SGPL1 signaling that enhances mitochondria–lysosome membrane contact sites, establishing a second organelle-contact function for VPS39 beyond its yeast PE transport role and linking it to mitochondrial network maintenance under calcium stress.\",\n      \"evidence\": \"Quantitative proteomics, transcriptomics, biochemical fractionation, MCS imaging in MICU1-deficient mammalian cells and C. elegans\",\n      \"pmids\": [\"35452878\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular determinants of VPS39 recruitment to MCS not defined\",\n        \"Whether HOPS-dependent and MCS functions are mutually exclusive is untested\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"ASFV protein CP204L was found to bind VPS39 and redirect it from the HOPS complex to virus factories, demonstrating that a second unrelated virus independently exploits VPS39 sequestration to reprogram endolysosomal trafficking for replication.\",\n      \"evidence\": \"Co-immunoprecipitation, proximity ligation, fluorescence colocalization, VPS39 knockout/knockdown with viral replication assays\",\n      \"pmids\": [\"36722971\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether CP204L and ORF3a bind overlapping VPS39 surfaces is unknown\",\n        \"Single lab; independent confirmation pending\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of VPS39 interactions with Rab GTPases, SNAREs, and viral proteins; how VPS39 is partitioned between HOPS-dependent fusion, HOPS-independent lipid transport, and membrane contact site functions; and whether VPS39's autophagy–epigenetic axis in muscle extends to other metabolic tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of full-length VPS39 or VPS39 in complex with HOPS/RAB7/STX17\",\n        \"Molecular switch governing HOPS-dependent versus HOPS-independent VPS39 pools is uncharacterized\",\n        \"In vivo relevance of VPS39 in human metabolic disease requires genetic association data\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 5, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0, 2, 3, 7, 8]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [6, 8, 10]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [11, 13]},\n      {\"term_id\": \"GO:0005773\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2, 7, 8, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [7, 8, 9, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [11, 15]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [12, 13]}\n    ],\n    \"complexes\": [\n      \"HOPS complex\",\n      \"CORVET complex\"\n    ],\n    \"partners\": [\n      \"VPS41\",\n      \"VPS33A\",\n      \"VPS16\",\n      \"STX17\",\n      \"RAB7\",\n      \"RAB5\",\n      \"GTR1\",\n      \"SGPL1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}